VIR
Vir Biotechnology Inc
NASDAQ · Biotechnology
$7.19
+0.27 (+3.90%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 76.61M | 187.96M | 123.81M | 113.39M | 105.81M |
| Net Income | -538,918,332 | -1,189,957,062 | -39,256,908 | -30,823,495 | -32,439,743 |
| EPS | — | — | — | — | — |
| Profit Margin | -703.4% | -668.2% | -31.7% | -27.2% | -30.7% |
| Rev Growth | -59.2% | -59.2% | -9.5% | +24.3% | +5.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 0 | 0 | 373.26M | 432.19M | 355.41M |
| Total Equity | — | — | 409.83M | 459.65M | 428.15M |
| D/E Ratio | — | — | 0.91 | 0.94 | 0.83 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -608,227,928 | -1,417,606,799 | -51,056,784 | -42,153,177 | -39,538,454 |
| Free Cash Flow | — | — | -17,401,569 | -22,930,380 | -17,215,226 |